APA (7th ed.) Citation

Claudiani, S., Parker, E. L., Milojkovic, D., Rosadas, C., Khan, A., Katsanovskaja, K., . . . Apperley, J. F. (2022). Long-term persistence of natural anti-SARS-CoV-2 antibodies and mild impact of SARS-CoV-2 infection in CML patients: Results from a seroprevalence study. Leukemia & Lymphoma, 63(6), 1504. https://doi.org/10.1080/10428194.2022.2027403

Chicago Style (17th ed.) Citation

Claudiani, Simone, et al. "Long-term Persistence of Natural Anti-SARS-CoV-2 Antibodies and Mild Impact of SARS-CoV-2 Infection in CML Patients: Results from a Seroprevalence Study." Leukemia & Lymphoma 63, no. 6 (2022): 1504. https://doi.org/10.1080/10428194.2022.2027403.

MLA (9th ed.) Citation

Claudiani, Simone, et al. "Long-term Persistence of Natural Anti-SARS-CoV-2 Antibodies and Mild Impact of SARS-CoV-2 Infection in CML Patients: Results from a Seroprevalence Study." Leukemia & Lymphoma, vol. 63, no. 6, 2022, p. 1504, https://doi.org/10.1080/10428194.2022.2027403.